A primary goal of the AFFIRM Relationships project was to engage the transgender community in the research at various stages, including during the design of the research studies, when interpreting results, and when working out what these results mean for clinical care and the community. This involved setting up a consultancy group of transgender people and their loved ones, such as romantic partners or family members, to brainstorm research priorities and gather and implement feedback on study design and material selection. This practice has informed our research and provides ongoing insights that are fundamental to the continued success of the project. Related to this, we also conducted 26 in-depth interviews with transgender people on the topics of psychological and social well-being over the course of gender-affirming hormone therapy. These interviews provided important insights on the role that hormones may play in the daily lives of transgender people, such as changes in mood and social life, and whether transmen, transwomen, and nonbinary people experience potential changes differently. Findings from these interviews have helped us further develop the next steps in our research.
In addition to collecting new data from participants, we aim to maximize current knowledge available in existing data repositories. For example, we analyzed available data from several sources, including the World Health Organization and the Transgender EU Health Map, to group European countries based on quality of and access to gender-affirming medical care. This type of data provides insight on the role that structural and societal factors play in the well-being of transgender people, alongside gaining better understanding of how hormone therapy is provided across culturals and contexts within which transgender people are living and accessing care across Europe.
Coming up, we will be running a new study to understand the effects of sex hormones on social health during gender transition over a 2-year time span. We will be recruiting 300 transgender people starting different types of gender-affirming care: People starting gender-affirming hormone therapy, including both masculinizing and feminizing hormone therapy; people undergoing a mastectomy, which is a masculinizing top surgery to remove breast tissue; and people starting voice training to achieve a more feminine-sounding voice. Participants will be filling out surveys related to their psychological health, such as their mood and self-esteem, and social well-being, including satisfaction with close relationships and support from others, at the start of gender-affirming care, and then again at 3, 6, 12, and 24 months after starting their treatment. This project will allow us to disentangle the biological, medical, and social aspects of gender-affirming care that may influence well-being for transgender people.